DPD Deficiency Foundation | Grafton MA
Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier | British Journal of Cancer
DPD Biomarker | Colorectal Cancer Alliance
Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature - ESMO Open
JCM | Free Full-Text | In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase
Dihydrofluorouracil - an overview | ScienceDirect Topics
DPD Gene Mutations (5-FU toxicity) detection test in Alwar
TRUPCR® DPYD Mutation Detection Kit | TRUPCR Europe
The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study | British Journal of Cancer
Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time - ScienceDirect
DPD-dependent inactivation of 5-FU and effects of DPD deficiency. For... | Download Scientific Diagram
DPYD*2A mutation: the most common mutation associated with DPD deficiency | SpringerLink
Dihydropyrimidine Dehydrogenase - an overview | ScienceDirect Topics
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update - Annals of Oncology
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in the United Kingdom - ScienceDirect
Cancers | Free Full-Text | Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy
Pharmaceutics | Free Full-Text | DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
Localization of the point mutation sites in the DPD crystal structure | Download Scientific Diagram
Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12 - Kuilenburg -
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity | Pharmacogenomics
DPD Biomarker | Colorectal Cancer Alliance
Dihydropyrimidine dehydrogenase deficiency: MedlinePlus Genetics
Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy | Pharmacogenomics
